Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03980171
Title Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma (LEVERAGE)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications

follicular lymphoma

Therapies

Lenalidomide + Obinutuzumab + Venetoclax

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
The University of Texas MD Anderson Cancer Center Withdrawn Houston Texas 77030 United States Details
Peter MacCallum Cancer Centre Recruiting Melbourne Victoria 3000 Australia Details
Sir Charles Gairdner Hospital Recruiting Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field